What hormone is in the Mirena (levonorgestrel) IUD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hormone in the Mirena IUD

The Mirena IUD contains levonorgestrel, a synthetic progestin hormone, which is released at a rate of approximately 20 micrograms per 24 hours. 1, 2

Details about Mirena's Hormone Content

  • Mirena is a hormonal intrauterine device (IUD) that contains 52 mg of levonorgestrel 1
  • The hormone is contained in a silastic reservoir attached to the vertical arm of the device, covered by a rate-limiting silastic membrane that controls the release rate 3
  • Initially, the release rate is higher, but stabilizes to approximately 20 micrograms of levonorgestrel per day for at least 5 years 3, 2
  • Plasma concentrations of levonorgestrel are highest in the first three months (mean 260 pg/ml) and decrease to lower levels (mean 129 pg/ml) after one year of treatment 4

Mechanism and Local Effects

  • The levonorgestrel is released directly into the uterine cavity, causing pronounced endometrial suppression 3
  • The dose is low enough that systemic effects are minimal, with negligible impact on ovarian function in most women 3
  • This localized hormone delivery system allows for effective contraception with lower systemic hormone exposure compared to oral contraceptives

Duration of Use and Effectiveness

  • Mirena is FDA-approved for use for 5-7 years 1
  • It has an extremely high contraceptive efficacy with a Pearl index (pregnancy rate) of only 0.09 5, 3
  • The low failure rate makes it one of the most effective reversible contraceptive methods available

Other Levonorgestrel IUDs

For comparison, other levonorgestrel-releasing IUDs include:

  • Skyla (13.5 mg levonorgestrel) - approved for 3 years
  • Liletta (52 mg levonorgestrel) - approved for 3 years
  • Kyleena (19.5 mg levonorgestrel) - approved for 5 years 1

Clinical Considerations

  • The local release of levonorgestrel provides additional non-contraceptive benefits, including reduction in menstrual bleeding and improvement in dysmenorrhea 2
  • Common side effects include changes in bleeding patterns, particularly in the first 3-6 months, which may include irregular spotting or light bleeding 1
  • Some women (approximately 28.6%) may develop amenorrhea with prolonged use 6
  • The levonorgestrel IUD can be particularly beneficial for women with heavy menstrual bleeding, as it significantly reduces menstrual blood loss 6, 2

Understanding that Mirena contains levonorgestrel is important for patients considering this contraceptive option, especially those with contraindications to certain hormones or those seeking the non-contraceptive benefits of this IUD.

References

Guideline

Management of Dyspareunia in IUD Users

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The levonorgestrel intrauterine system: more than a contraceptive.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2001

Research

Hormonal intrauterine devices.

Annals of medicine, 1993

Research

Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.